Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa).
Eichler M, Pink D, Menge F, Jakob J, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D, Singer S, Grützmann R, Dmytrow DI, Arndt K, Tuchscherer A, Reichardt P, Ahrens M, Kunitz A, Mohm J, Bornhäuser M, Schmitt J, Schuler MK. Eichler M, et al. Among authors: mohm j. Eur J Cancer Care (Engl). 2021 Nov;30(6):e13484. doi: 10.1111/ecc.13484. Epub 2021 Aug 3. Eur J Cancer Care (Engl). 2021. PMID: 34342924
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied.
Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Büssing B, Novotny J, Ganser A, Duyster J, Bunjes D, Westermeier T, Flohr T, Desprès D, Gamm H, Decker J, Derigs G, Aulitzky W, Huber C. Fischer T, et al. Among authors: mohm j. Ann Hematol. 1998 Jul-Aug;77(1-2):21-6. doi: 10.1007/s002770050406. Ann Hematol. 1998. PMID: 9760148 Clinical Trial.
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML.
Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Büssing B, Novotny J, Ganser A, Duyster J, Bunjes D, Kreiter S, Aulitzky W, Hehlmann R, Huber C. Fischer T, et al. Among authors: mohm j. Bone Marrow Transplant. 1998 May;21(10):1029-36. doi: 10.1038/sj.bmt.1701229. Bone Marrow Transplant. 1998. PMID: 9632277
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO).
Jotschke S, Schulze S, Jaekel N, Ludwig-Kraus B, Engelmann R, Kraus FB, Zahn C, Nedlitz N, Prange-Krex G, Mohm J, Peuser B, Schwarz M, Spohn C, Behlendorf T, Binder M, Junghanss C, Böttcher S, Al-Ali HK. Jotschke S, et al. Among authors: mohm j. Cancers (Basel). 2022 Mar 17;14(6):1544. doi: 10.3390/cancers14061544. Cancers (Basel). 2022. PMID: 35326695 Free PMC article.
Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma-data from the prospective German Tumour Registry Lymphatic Neoplasms.
Knauf W, Abenhardt W, Mohm J, Rauh J, Harde J, Kaiser-Osterhues A, Jänicke M, Marschner N; TLN-Group (Tumour Registry Lymphatic Neoplasms). Knauf W, et al. Among authors: mohm j. Eur J Haematol. 2019 Nov;103(5):460-471. doi: 10.1111/ejh.13295. Epub 2019 Sep 4. Eur J Haematol. 2019. PMID: 31314918 Clinical Trial.
13 results